Cost-Effectiveness of Current Therapeutic Strategies for Melanoma.
1/5 보강
The treatment landscape for melanoma has been dramatically transformed by the advent of novel therapeutic approaches, particularly immune checkpoint inhibitors (ICIs) and targeted therapies (TTs).
APA
Goto H (2025). Cost-Effectiveness of Current Therapeutic Strategies for Melanoma.. Current treatment options in oncology, 27(1), 2. https://doi.org/10.1007/s11864-025-01370-0
MLA
Goto H. "Cost-Effectiveness of Current Therapeutic Strategies for Melanoma.." Current treatment options in oncology, vol. 27, no. 1, 2025, pp. 2.
PMID
41460400 ↗
Abstract 한글 요약
The treatment landscape for melanoma has been dramatically transformed by the advent of novel therapeutic approaches, particularly immune checkpoint inhibitors (ICIs) and targeted therapies (TTs). Clinical outcomes, such as overall survival, progression-free survival, objective response rate, and the incidence of immune-related adverse events, are useful metrics for evaluating these agents; however, cost considerations have become increasingly important. Globally, the medical costs associated with melanoma treatment are increasing. In recent years, the cost-effectiveness of ICIs and TTs in both unresectable and adjuvant settings has been extensively analyzed. Most studies have reported that anti-PD-1 antibody monotherapy is more cost-effective than combination regimens involving ICIs or TTs in both settings. However, most cost-effectiveness analyses were based on simulation models derived from international clinical trials data; therefore, they may not accurately reflect real-world outcomes, which can vary significantly among different patient populations. Furthermore, treatment costs vary substantially among countries due to differences in healthcare systems, reimbursement policies, and pricing. Cost-effectiveness analyses based on real-world data from individual countries are essential to accurately determine the most cost-effective treatment options for patients with melanoma.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunities.
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.